S54 - Motor Neuron Disease
| Event Time: | Thursday May 9, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Neuromuscular and Clinical Neurophysiology (EMG) |
| Director(s): | |
| Description: | |
| Completion Message: | |
| CME Credits: | 2 |
| Core Competencies: |
| Start/End Time | Title | Faculty |
|---|---|---|
| 5:10 PM - 5:30 PM | Q&A Panel with Authors | Faculty |
| Speaker | Disclosure |
|---|
| Start Time | Pub. | Title | Presenter |
|---|---|---|---|
| 3:30 PM | 001 | Heritability of ALS: A Population-based study over 24 years. |
Disclosure: Dr. Ryan has nothing to disclose.
|
| 3:30 PM | 002 | The Clinical and Neuroimaging Features of Primary Lateral Sclerosis |
Disclosure: Dr. Finegan has nothing to disclose.
|
| 3:30 PM | 003 | Clinical findings in amyotrophic lateral sclerosis type 4 |
Disclosure: Dr. Grunseich has nothing to disclose.
|
| 3:30 PM | 004 | Pathological and Behavioral Characterization of Transgenic Mice Expressing ALS-Associated CHCHD10-R15L |
Disclosure: Dr. Ryan has nothing to disclose.
|
| 3:30 PM | 005 | Distinct patterns of cerebellar damage in sporadic and C9ORF72-related ALS |
Disclosure: Dr. Borba has nothing to disclose.
|
| 3:30 PM | 006 | A Novel Muscle Cramp Scale for Patients with ALS |
Disclosure: Dr. Mitsumoto has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Mitsubishi-Tanabe Pharma. Dr. Mitsumoto has received research support from Tsumura; Co, Cytokinetics.
|
| 3:30 PM | 007 | Correlation of cognitive impairment and KING’s and MiTos staging in ALS: a cross-sectional population-based study. |
Disclosure: Dr. Vasta has nothing to disclose.
|
| 3:30 PM | 008 | Differentially Expressed microRNA Profile in Skeletal Muscle Tissue of Sporadic ALS Patients |
Disclosure: Dr. Kurt has nothing to disclose.
|
| 3:30 PM | 009 | Retrospective review of respiratory function in the Amyotrophic Lateral Sclerosis(ALS) veteran population with and without Edaravone therapy. |
Disclosure: Dr. Thakore-James has nothing to disclose.
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 9:30 AM-11:30 AM |
|---|
|
C12 -
Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing
Tahseen Mozaffar MD, FAAN |
| 1:30 PM-3:30 PM |
|
C25 -
Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology
Tahseen Mozaffar MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C46 -
Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder)
Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN |
|
C36 -
Mastering EMG Waveform Recognition Skills in Just Two Hours!
Devon Rubin MD, FAAN |
| 1:00 PM-3:00 PM |
|
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
|
C47 -
Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies
Amanda Peltier MD, MS |
|
S5 -
Therapeutics in ALS and SMA
|
| 3:30 PM-5:30 PM |
|
C65 -
Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia
Amanda Peltier MD, MS |
| 11:30 AM-6:30 PM |
|---|
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C101 -
Clinical EMG I: Principles and Practice of NCS and Needle EMG
Ruple Laughlin MD, FAAN |
|
N2 -
Neuroscience in the Clinic: Interpretations of Genetic Results
Karen Marder MD, MPH, FAAN, Massimo Pandolfo MD, FAAN |
| 3:30 PM-4:45 PM |
|
S18 -
Autonomic Disorders
|
| 3:30 PM-5:30 PM |
|
C120 -
Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography
Ruple Laughlin MD, FAAN |
|
S23 -
Genetic Muscle Disorders
|
| 7:00 AM-9:00 AM |
|---|
|
C121 -
Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches
Mark Bromberg MD, PhD, FAAN |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
C131 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System
Christopher Gibbons MD, FAAN |
|
S25 -
Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
|
| 1:00 PM-5:30 PM |
|
C148 -
Skills Workshop: EMG: Basic
(Registration Required)
Holli Horak MD, FAAN |
| 3:30 PM-5:30 PM |
|
C150 -
Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System
Christopher Gibbons MD, FAAN |
|
Presentation of the Sheila Essey Award: An Award for ALS Research
|
| 7:00 AM-9:00 AM |
|---|
|
C171 -
Child Neurology: Neuromuscular/Autoimmune Neurology
Anne Connolly MD, FAAN |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
C175 -
Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia
Laura Tormoehlen MD, FAAN |
|
N4 -
Neuroscience in the Clinic: Immunotherapies in Neurological Disease
John Corboy MD, FAAN, Holly Hinson MD, MCR, FAAN |
| 1:00 PM-5:30 PM |
|
C191 -
Skills Workshop: Neuromuscular Ultrasound
(Registration Required)
Craig Zaidman MD |
| 3:30 PM-5:30 PM |
|
C192 -
Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission
Laura Tormoehlen MD, FAAN |
|
C195 -
Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease
Madhu Soni MD, FAAN |
|
S42 -
Neuromuscular Disorders
|
| 7:00 AM-9:00 AM |
|---|
|
C205 -
Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies
David Herrmann MD, FAAN |
|
C214 -
Child Neurology: A Case-based Approach
Elaine Wirrell MD, FAAN |
| 11:30 AM-6:30 PM |
|
P5 -
Poster Session 5
|
| 1:00 PM-3:00 PM |
|
C215 -
Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies
Michelle Mauermann MD, FAAN |
| 3:30 PM-5:30 PM |
|
C229 -
Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives
Mario Saporta MD, PhD, FAAN |
| 7:00 PM-10:00 PM |
|
C237 -
Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease
Robert Pascuzzi MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C243 -
Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis
Michael Weiss MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S58 -
Therapeutics in Neuromuscular Disorders
|
| 2:00 PM-2:45 PM |
|
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1
Nicholas Johnson MD, FAAN |
|
Consensus-Based Care Recommendations for Adults with haha
|